1. Document de presse | 2021.11.26

   ComCor study: new results on places of infection with SARS-CoV-2 and analysis of the efficacy of messenger RNA vaccines against the Delta variant

   From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus in France. The aim of the study was to identify the socio-demographic factors, places visited and...

2. News | 2021.11.30

   Composition of the gut microbiota modulates the severity of Clostridioides difficile infection

   During infection, the pathogenic bacterium interacts closely with the bacteria in the gut. They may have to share resources, thereby limiting infection with the pathogen, or alternatively the pathogen may draw benefits from this cohabitation for its infectious strategy.Infection with Clostridioides difficile is the main cause of infectious diarrhea in hospitals and long-term care facilities....

3. Document de presse | 2021.12.01

   Virus related to SARS-CoV-2 found in bats in Cambodia

   What are the origins of SARS-CoV-2? This is the world’s most pressing scientific puzzle. Its pieces scattered throughout the world are currently being sought out by scientists. Their goal: to track down the culprit for the largest health crisis to hit the globe in the past century. Scientists at the Institut Pasteur in Paris and the Institut Pasteur du Cambodge have identified a coronavirus in...

4. Document de presse | 2021.12.06

   Chronic obstructive pulmonary disease: a genetic mutation confirmed as predisposing factor

   In 2019, the WHO positioned chronic obstructive pulmonary disease (COPD) third in the global ranking of causes of death. However, some mechanisms of this debilitating chronic respiratory disease are yet to be identified. Against this backdrop, scientists at the Institut Pasteur, Université de Paris, CNRS, Inserm, University of Reims Champagne-Ardenne, Reims University Hospital and the Institut...

5. News | 2021.12.14

   2022: the bicentenary of Louis Pasteur's birth

   Louis Pasteur was born on December 27, 1822. He was an international figure in scientific and medical research and the founder of the Institut Pasteur (Paris) in 1887. Louis Pasteur was a precursor of a certain way of conducting research, deeply concerned with its goals, both humanistic and universal, and the need to train and transmit this approach and these values to future generations. Today,...

6. Document de presse | 2021.12.10

   COVID-19 patients in ICUs: Study reveals an increased risk of invasive fungal secondary infections

   What if certain fungi exacerbate respiratory distress in individuals with covid-19? The mycovid study published in the lancet respiratory medicine yields its initial results. Teams at Rennes University Hospital – University of Rennes 1, Necker-Enfants Malades Hospital (part of the Paris Public Hospital Network or AP-HP), Georges-Pompidou European Hospital (AP-HP) – Université de Paris, Avicenne...

7. Document de presse | 2021.12.23

   COVID-19 – Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose

   The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial epidemiological studies show that the Omicron variant is more transmissible than the currently dominant virus (the Delta variant). It is capable of spreading to individuals who have received...

8. Document de presse | 2022.01.11

   Identification of a novel therapeutic target in Multiple Myeloma

   Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. Proteasome inhibitors, the therapeutic backbone of current treatments, are very effective in treating newly diagnosed cancers but resistance or intolerance to these molecules inevitably develop, leading to relapses. While studying a neglected tropical disease[1], Buruli ulcer, researchers...

9. Page avancée | 2022.01.12

   Institut Pasteur publications about SARS-CoV-2 / Covid-19

   The Institut Pasteur’s list of scientific publications on SARS-CoV-2 coronavirus and Covid-19 disease.

10. News | 2022.01.12

    French Prime Minister Jean Castex salutes the Institut Pasteur's expertise on emerging infectious diseases

    French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on Monday January 10, 2022, to salute the efforts of scientists in the ongoing battle against COVID-19. The visit was an opportunity to highlight the need to strengthen preparedness for future emerging diseases. It was also an auspicious moment...

Pages